Trial Profile
LIRAGLUTIDE AND ORLISTAT TREATMENT FOR PERSISTENT TYPE 2 DIABETES AFTER GASTRIC BANDING: A PILOT STUDY
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Orlistat (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 Jan 2018 Status changed from recruiting to discontinued.
- 13 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 18 May 2012 New trial record